Improving blood management practices in Central Eastern Europe hospitals
Evaluation of Fixed and Personal Assets for Patient Blood Management Implementation in CEE Countries in Practice
This study is testing how well hospitals in Central Eastern Europe can improve their blood management practices to better care for patients and reduce unnecessary blood transfusions after they receive training.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Semmelweis University Academic / other |
| Locations | 1 site (Budapest) |
| Trial ID | NCT06878105 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on the implementation of Patient Blood Management (PBM) practices in hospitals across Central Eastern Europe. It focuses on assessing the current state of blood management before and after training interventions, with the goal of optimizing patient care and reducing unnecessary blood transfusions. The study will involve self-audits to evaluate the effectiveness of PBM protocols and the management of anemia and bleeding in surgical patients. Investigators will analyze patient-level data during two one-week snapshot periods, one at the start and another six months post-training.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old undergoing elective surgeries with a moderate to high risk of bleeding.
Not a fit: Patients who may not benefit include those under 18 years old, pregnant individuals, or those undergoing low-risk or emergency surgeries.
Why it matters
Potential benefit: If successful, this study could lead to improved patient outcomes through better management of anemia and reduced reliance on blood transfusions.
How similar studies have performed: Previous research has indicated gaps in PBM implementation in the CEE region, suggesting that this approach is necessary and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients above 18 years of age * patients undergoing elective medium and high bleeding risk surgical intervention defined as moderate (\<500 ml) and high (≥ 500 ml) * patient consent Exclusion Criteria: * no patient consent * patients under 18 years of age * pregnant patients * surgery with a low risk of bleeding * the patient underwent emergency (non-elective) surgery
Where this trial is running
Budapest
- Semmelweis University — Budapest, Hungary (Recruiting)
Study contacts
- Study coordinator: János Fazakas, Ass Prof
- Email: jancsidora@gmail.com
- Phone: +36208258560
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.